In support of these findings, ApoA1 transgenic mice have shown lower fasting glucose levels and improved glucose tolerance compared with wild-type mice [112,114], and a recent study found that a short peptide RG54 derived from ApoA1 induced glucose uptake in cultured muscle myotubes [115]. The gene discussed is APOA1; the disease is glucose measurement.